55 /100
HIGH RISK
Score updated May 30, 2026

IMA — ImageneBio, Inc. Dilution Risk Tracker

Track IMA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
45%
📜 Warrant Exercise 60%
• Massive warrant overhang: 51% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 40%
• Score rose 31 points recently (worsening)
💰 Capital Raise 18%
• Active ATM program with $30M remaining capacity
🔔 Track IMA — Get forecast alerts →

💹 Market Data

Market Cap$66.32M
Shares Outstanding11.28M
Float5.80M
Cash$117.21M
Debt$2.42M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 17.1% shares (2025Q4 vs prior)
40 institutional holders · 5.56M shares
#1 Blue Owl Capital Holdings LP 1.65M shares
#2 BVF INC/IL 802.1K shares
#3 Cable Car Capital, LP 643.9K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest445.0K
Days to Cover6.4
% of Float7.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Apr 16, 2026
4 INSIDER TRANSACTION Apr 16, 2026
3 FORM3 Apr 16, 2026
424B3 ATM Apr 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track IMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IMA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for IMA
📊 IMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IMA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.